Kewaunee Scientific Corporation: stock overview

KEQUNASDAQIndustrials · Laboratory Apparatus & Furniture

Price

$35.70

November 13, 2026Market cap $102M

What Ploutos Investor adds for Kewaunee Scientific

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

In short

Kewaunee Scientific had revenue of $277M over the last 12 months and net income of $8.2M, a net margin of 3.0%. Revenue grew by 13.8% a year on average over the last 5 years. At $35.70 the shares trade at a P/E of 12.5, against a median of 9.9 over the last 4 fiscal years. It pays no dividend.

From its SEC filings (latest fiscal year to April 30, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$102M
2.87M shares
P/E
12.5
Today12.5
Median9.9
Revenue, 12 months
$277M
+13.8% a year over 5 years
Net margin
3.0%
FY2025: 3.4%, above 57% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+17.6% a year over 2 years

  • FY2026Apr 30, 202610-K
    Revenue$282M
  • FY2025Apr 30, 202510-K
    Revenue$240M
  • FY2024Apr 30, 202410-K
    Revenue$204M

Fiscal years in figures

KEQU's revenue, profit, cash flow and dividend with each year-end price, from FY2010 to FY2023, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $101M
$102M
Enterprise value 
–
P/E 3-year median: 8.3
12.5
EV / EBIT 
–
EV / Revenue 
–
P/B 3-year median: 1.4
1.4
FCF yield 3-year median: 14.0%
10.6%
Earnings yield 3-year median: 12.1%
8.0%

Profitability

Gross margin 
28.5%
Operating margin 
5.4%
Net margin 3-year median: 4.7%
3.0%
ROIC 
11.4%
ROIC, 5-year average 
11.5%
ROE 
11.5%

Growth

Revenue, yearly change 
+17.3%
EPS, yearly change 
-15.9%
FCF, yearly change 
+16.5%
Revenue, average a year 
+13.8%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$8.2M
Total debt 
–
Net cash 
–
Net debt / EBITDA 
–
Interest cover 
3.5x
Current ratio 
2.20

Balance sheet of July 31, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+0.9%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).

Gross margin

28.5%

Above 8% of the 161 companies in its industry, and 35% of all.

Operating margin

5.9%

Above 55% of the 186 companies in its industry, and 53% of all.

Net margin

3.4%

Above 57% of the 189 companies in its industry, and 47% of all.

ROE

13.6%

Above 77% of the 174 companies in its industry, and 73% of all.

ROA

5.5%

Above 68% of the 190 companies in its industry, and 74% of all.

Revenue growth

17.3%

Above 77% of the 186 companies in its industry, and 77% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
KEWAUNEE SCIENTIFIC CORP /DE/
Exchange
NASDAQ
Industry (SIC)
3821 · Laboratory Apparatus & Furniture
Fiscal year ends
April 30
Latest annual report
April 30, 2026
Reporting currency
USD
Shares
2.87M

Other companies: Industrials

The largest companies of the same sector, each with its own page.

The Industrials sectorAll companies

The full analysis

What do Kewaunee Scientific's filings show?

These are Kewaunee Scientific's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about KEQU

Didn't find what you were looking for?

Ask us
What is KEQU's market cap?

Kewaunee Scientific Corporation's market cap is $102M, at a price of $35.70 on November 13, 2026 and 2.87M shares.

What is KEQU's P/E?

KEQU's P/E is 12.5, on earnings per share of $2.76 over the last 12 months. The median over the last 4 fiscal years was 9.9.

How much revenue does KEQU have?

Kewaunee Scientific had revenue of $277M over the last 12 months. Over the last 5 years it changed by +13.8% a year on average.

Does KEQU pay a dividend?

No. Kewaunee Scientific paid no regular dividend over the last 12 months.

Where do the figures come from?

From Kewaunee Scientific Corporation's SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.